Eli Lilly to Combat Generics (NYSE: LLY),(NYSE: BMY),(NYSE: MRK)

Eli Lilly & Co. (NYSE:LLY)

The CEO of Eli Lilly & Co. (NYSE:LLY), John Lechleiter, has this to say, “Many companies are seeking to lower risk by reducing their focus on innovative medicines. This is not our path.” 

Bristol-Myers shares look attractive

Investing Ideas (5)

Bristol Myers Squibb Co. (NYSE:BMY) shares are down in the $19 range and down 3% in the last month.  Bristol-Myers Squibb is a moderate-risk stock at this point.

Syndicate content

WallStNation.comThanks for visiting WallStNation.com, to assist your investing research try using our Search (click to access) or review the list of Tickers (click to access) that link directly to articles related to the given stock/security.

To Browse our Most Recent Stories (click here)

Share WallStNation.com Content

Share this article with others, WallStNation.com is the Independent Wall Street Newspaper. Thanks for Reading!

Daily Market Summary

Please Review the WallStNation.com Disclaimer and remember that information provided by our site is at the investor's sole financial risk. Please Review for more Details